Multiple system atrophy (MSA) and CASPR2 antibody-associated disease bear their own characteristics.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: